Safety & Efficacy of Lastacaft® for the Prevention of Itching Associated

See also
Status	Clinical Trial	Phase
Completed	`NCT00501527` - Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense	Phase 2
Completed	`NCT00422149` - Twin SUBLIVAC® Grasses Clinical Efficacy Study	Phase 3
Completed	`NCT01470118` - A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis	Phase 4
Completed	`NCT03709121` - A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber	Phase 1/Phase 2
Completed	`NCT01732757` - A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis	Phase 4
Recruiting	`NCT04299399` - Corneal Biomechanical Changes of Allergic Conjunctivitis
Completed	`NCT00917488` - Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).	Phase 2
Completed	`NCT03375775` - Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children	N/A
Completed	`NCT02082262` - AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis	Phase 3
Withdrawn	`NCT01541904` - Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis	Phase 2
Completed	`NCT00311844` - A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)	Phase 4
Completed	`NCT02161146` - AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis	Phase 3
Completed	`NCT00718744` - Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units	Phase 2
Recruiting	`NCT03186755` - Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis	Phase 4
Completed	`NCT01987765` - Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea	N/A
Completed	`NCT06063044` - Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children
Completed	`NCT01289431` - Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis	Phase 2
Completed	`NCT00655109` - A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis	Phase 4
Completed	`NCT00424398` - Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis	Phase 2/Phase 3
Completed	`NCT03012165` - A Study of ADX-102 in Subjects With Allergic Conjunctivitis	Phase 2

NCT number	NCT02555761
Study type	Observational
Source	Allergan
Contact
Status	Completed
Phase
Start date	October 19, 2015
Completion date	March 19, 2018

Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms